SCHEMBL722446

SCHEMBL722446

[c]1ccccc1-c1cn2c(-c3ccccc3)cccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 5/20 0.43
MAP2K1 Q02750 2/20 0.43
MAP4K4 O95819 1/20 0.43
CSF1R P07333 1/20 0.43
PRKACA P17612 1/20 0.43
KDR P35968 1/20 0.43
CDK8 P49336 1/20 0.43
ACVR1 Q04771 1/20 0.43
MAP4K2 Q12851 1/20 0.43
ROCK1 Q13464 1/20 0.43
DYRK1A Q13627 1/20 0.43
AURKB Q96GD4 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
GSK3B P49841 1/20 0.40
NTRK1 P04629 1/20 0.39
IGF1R P08069 1/20 0.39
FGFR1 P11362 1/20 0.39
LTK P29376 1/20 0.39
MAP2K2 P36507 1/20 0.39
MAPK9 P45984 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722447 0.79 NTRK1 (0.48) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL370701 0.72 RAB9A (0.51) MAPTALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL13454283 0.72 NTRK1 (0.47) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL13454268 0.72 NTRK1 (0.47) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL12920622 0.71 CHEK1 (0.50) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL103694 0.71 NUDT1 (0.47) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL715045 0.71 MEN1 (0.61) PRKACAMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL13133710 0.71 NTRK1 (0.46) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL29080578 0.68 FGFR1 (0.53) CHEK1MAP2K1MAP4K4CSF1RPRKACA
SCHEMBL21377621 0.68 CHEK1 (0.46) CHEK1MAP2K1MAP4K4CSF1RPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 CHEK1 2371/4885MAP2K1 4022/4885MAP4K4 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.